SCHEMBL12396017

SCHEMBL12396017

Cc1ccc(C(=O)Nc2cc(-c3ccc(F)cc3F)sc2C(=O)O)cc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
POLB P06746 2/20 0.54
MAPT P10636 2/20 0.54
CRHBP P24387 1/20 0.54
CRHR2 Q13324 1/20 0.54
KDM4E B2RXH2 1/20 0.51
P2RY14 Q15391 4/20 0.49
NPC1 O15118 4/20 0.49
RAB9A P51151 3/20 0.49
GAA P10253 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PTPN1 P18031 1/20 0.46
KCNMA1 Q12791 1/20 0.46
CHEK1 O14757 2/20 0.44
ALDH1A1 P00352 1/20 0.43
HTT P42858 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HDAC1 Q13547 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12396010 0.82 MEN1 (0.60) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL12396015 0.82 POLB (0.73) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL3082478 0.81 CHEK1 (0.59) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL2157985 0.78 POLB (0.67) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL12396006 0.78 NPC1 (0.56) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL2158166 0.76 GPBAR1 (0.40)
SCHEMBL12396019 0.76 PTPN1 (0.64) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL19392337 0.76 NPC1 (0.71) KMT2APOLBMAPTNPC1RAB9A
SCHEMBL12396100 0.75 KMT2A (0.52) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL10708218 0.73 KCNMA1 (0.61) MEN1KMT2APOLBMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985769-B2 Compounds and methods for the treatment or prevention of Flavivirus infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-26 US disclosed
US-7985769-B2 Compounds and methods for the treatment or prevention of Flavivirus infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-26 US disclosed
EP-2206709-A2 Thiophene derivatives as antiviral agents for flavivirus infection Virochem Pharma Inc. (CA) 2010-07-14 EP disclosed